Kajal Patel, DDS
Dentist · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 30 years
- Graduated 1996
Offices
2 locations
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Patel’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A43838 · Cancelled
Licence status: Cancelled · since 1987 · University of Alberta Faculty of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 13 Part D prescriptions in 2019. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2019 | 13 | None | 0% (0) | 0% | $2,686 |
| 2018 | 67 | 15 | None | None | $5,328 |
| 2017 | 111 | 15 | 0% (0) | 33% | $34,710 |
| 2016 | 133 | 15 | 0% (0) | 50% | $33,907 |
| 2015 | 125 | 18 | None | 49% | $18,126 |
| 2014 | 122 | 23 | None | 44% | $13,079 |
| 2013 | 65 | 17 | 0% (0) | 51% | $7,881 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Furosemide | 13 | $60 | $5 |
2017: 3 drugs
| Renvela | 12 | $15,182 | $1,265 |
| Amlodipine Besylate | 15 | $104 | $7 |
| Furosemide | 16 | $67 | $4 |
2016: 5 drugs
| Renvela | 18 | $21,498 | $1,194 |
| Uloric | 16 | $4,668 | $292 |
| Prazosin | 11 | $744 | $68 |
| Metoprolol | 16 | $123 | $8 |
| Furosemide | 17 | $103 | $6 |
2015: 5 drugs
| Renvela | 11 | $10,315 | $938 |
| Prazosin | 11 | $570 | $52 |
| Calcitriol | 14 | $407 | $29 |
| Furosemide | 20 | $63 | $3 |
| Amlodipine Besylate | 11 | $40 | $4 |
2014: 1 drug
| Allopurinol | 14 | $65 | $5 |
Money from drug and device companies
$16 in 2019
A payment is not proof that care is biased.
| GlaxoSmithKline | Bexsero | $16 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2019-07-31 | Bexsero | $16 |
Professional record
- NPI
- 1538278387
- Licence
- CA 43838California A43838: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 1223G0001X (1223G0001X)
- Mailing address
- 1531 Silver Pond Ln, San Jose, CA, 95138
- NPI first listed
- 2006-08-29
- NPI last updated
- 2009-06-29
This is when the NPI record was last certified, not a medical board exam.